Hims & Hers Health to Acquire Eucalyptus to Expand Global Consumer Digital Health Platform
February 19, 2026
Hims & Hers Health, Inc. has entered into a definitive agreement to acquire Eucalyptus, a digital healthcare provider with operations in Australia, the UK, Germany and expanding to Japan and Canada. The deal is valued at up to $1.15 billion and is expected to close in mid-2026, enabling Hims & Hers to expand internationally and deepen its presence in multiple existing markets.
- Buyers
- Hims & Hers Health, Inc. (NYSE: HIMS)
- Targets
- Eucalyptus
- Industry
- Healthcare Services
- Location
- Australia
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Hims & Hers Acquires Honest Health to Expand UK Footprint
June 14, 2021
Healthcare Services
Hims & Hers Health, Inc. agreed to acquire London-based vertical health platform Honest Health to accelerate the company's expansion into the United Kingdom and Western Europe. The acquisition adds Honest Health’s hair-loss telehealth clinic and compounding pharmacy/fulfillment capabilities to Hims & Hers’ multi-specialty telehealth platform; financial terms were not disclosed.
-
Hims & Hers Acquires Apostrophe
June 24, 2021
Healthcare Services
Hims & Hers Health, Inc. completed the acquisition of teledermatology specialist Apostrophe to deepen its personalized dermatology offering and integrate Apostrophe's clinical team and compounding pharmacy capabilities. The entire Apostrophe team will join Hims & Hers, with Apostrophe CEO Ben Holber becoming head of Hims & Hers' dermatology business line.
-
Hims & Hers Acquires ZAVA
June 3, 2025
Healthcare Services
Hims & Hers Health, Inc. agreed to acquire ZAVA, a leading European digital health and telemedicine platform, in an all-cash transaction to accelerate the company's expansion into the UK and launch operations in Germany, France and Ireland. The acquisition brings ZAVA’s ~1.3 million active customers and nearly 2.3 million consultations in 2024 onto Hims & Hers’ platform and is expected to be accretive by 2026.
-
Hims & Hers Acquires US-based Peptide Facility in California
February 21, 2025
Pharmaceuticals
Hims & Hers Health, Inc. has acquired a US-based peptide manufacturing facility in California to further verticalize its supply chain and expand domestic capabilities for personalized medications. The acquisition, which closed in early February, strengthens Hims & Hers’ ability to meet growing consumer demand for personalized healthcare and peptide-based treatments.
-
Firmament-backed e4health Acquires eCatalyst Healthcare Solutions
August 2, 2023
Healthcare Services
Firmament-backed e4health has acquired Phoenix-based eCatalyst Healthcare Solutions, a provider of outsourced medical coding, auditing, clinical documentation integrity (CDI), and health information management (HIM) services. The transaction expands e4health's mid-revenue cycle and HIM capabilities and the eCatalyst leadership team will remain with the combined business to accelerate growth.
-
Eruptr Acquires Medicom Health's HRA Business
December 14, 2021
Healthcare Services
Eruptr Holdings, Inc. has completed the acquisition of the health risk assessment (HRA) business line of Medicom Health, LLC, expanding Eruptr's digital marketing and patient engagement offerings for hospitals and health systems. The deal adds a market-leading HRA product that is complementary to Eruptr's existing HealthAware solution and supports capability expansion at scale; Eruptr is PE-backed by H.I.G. Growth Partners.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.